July 16, 2020
Medicago, a Canadian subsidiary of Mitsubishi Tanabe Pharma, has initiated a PI clinical trial in Canada of its COVID-19 vaccine candidate, MT-2766, it said on July 14. The company plans to begin a PII trial in October if the PI...read more